First lung cancer patient treated at HCA UK with pioneering bispecific antibody therapy
HCA UK’s The Harborne Hospital in Birmingham has become the first facility in the West Midlands to treat a lung cancer patient using bispecific antibody therapy, a significant advancement in the treatment of solid tumours, highlighting the hospital’s growing role in cutting-edge cancer care.